FDA says all ranitidine drugs should be recalled on safety concernsThe FDA has asked drugmakers to pull all prescription and over-the-counter products based on ranitidine off the market Share XFDA says all ranitidine drugs should be recalled on safety concernshttps://pharmaphorum.com/news/fda-says-all-ranitidine-drugs-should-be-recalled-on-safety-concerns/
Amarin hit hard as generics loom for fish oil drug VascepaGeneric drugmakers Hikma and Dr Reddy’s Laboratories have won a surprise victory in a US patent lawsuit that Share XAmarin hit hard as generics loom for fish oil drug Vascepahttps://pharmaphorum.com/news/amarin-hit-hard-as-generics-loom-for-fish-oil-drug-vascepa/
CHMP backs safety of anticoagulants after real-world studyThe EMA’s human drugs advisory committee has said that no change is needed to the use of direct Share XCHMP backs safety of anticoagulants after real-world studyhttps://pharmaphorum.com/news/chmp-backs-safety-of-anticoagulants-after-real-world-study/
Ogilvy Health promotes Ripal Patel to CFOOgilvy Health has promoted Ripal Patel from SVP, client financial services to chief financial officer (CFO). Patel has Share XOgilvy Health promotes Ripal Patel to CFOhttps://pharmaphorum.com/sales-marketing/ogilvy-health-promotes-ripal-patel-to-cfo/
Golin makes Ondine Whittington group managing directorOndine Whittington has been promoted to group managing director for Golin and Virgo Health London. Previously managing director Share XGolin makes Ondine Whittington group managing directorhttps://pharmaphorum.com/news/golin-virgo-health-ondine-whittington/
Avenir Global appoints Miranda Dini global healthcare leadAvenir Global has appointed Miranda Dini as global healthcare lead, adding to her ongoing leadership of the communications Share XAvenir Global appoints Miranda Dini global healthcare leadhttps://pharmaphorum.com/news/avenir-global-miranda-dini-healthcare/
Is Neil Woodford planning an audacious comeback?Just a few months after the collapse of his troubled investment fund, Neil Woodford is reported to be Share XIs Neil Woodford planning an audacious comeback?https://pharmaphorum.com/news/is-neil-woodford-planning-an-audacious-comeback/
‘Predatory’ drugmakers exploit FDA’s unapproved drug scheme; studyAn FDA mechanism designed to curb unapproved uses of medicines could be encouraging pharma companies to implement massive Share X‘Predatory’ drugmakers exploit FDA’s unapproved drug scheme; studyhttps://pharmaphorum.com/news/predatory-drugmakers-exploit-fdas-unapproved-drug-scheme-study/
MicroMass hires Rosanne Johnson as executive vice presidentPharmaceutical marketing agency MicroMass Communications has named Rosanne Johnson as its new executive vice president. In her role, Share XMicroMass hires Rosanne Johnson as executive vice presidenthttps://pharmaphorum.com/sales-marketing/micromass-hires-rosanne-johnson-as-executive-vice-president/
